Moving Through a Diabetes Slump, One Step at a Time
"You don’t have to control your thoughts; you just have to stop letting them control you." – Dan Millman Managing diabetes is not just…
This study is for those with scarring of the liver due to MASH (metabolic dysfunction-associated steatohepatitis), also sometimes called “fatty liver.” Participants will add a once-weekly injection of an investigational medicine or placebo to their current medications. The purpose of the study is to see if this investigational medicine is safe and effective in order to be used as a new treatment for MASH.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator